- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Coaching Changes
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: OWLT Baby products.
Posted on 11/13/23 at 6:17 pm to ATLsuTiger
Posted on 11/13/23 at 6:17 pm to ATLsuTiger
Liabilities
I’m no analyst but cash burn is insane. How is OWLT going to ramp up production? Untapped credit lines on deck?
Posted on 2/27/24 at 5:58 pm to LSUcam7
Owlet Announces $9 Million Private Placement Financing
ATLTiger still riding this through? I’ve been able to average down, and did really well on those lots.. but this bag is heavy!
ATLTiger still riding this through? I’ve been able to average down, and did really well on those lots.. but this bag is heavy!
Posted on 2/27/24 at 8:28 pm to LSUcam7
100%
All hurdles are cleared. They just have to execute now.
I honestly see them clawing their way back a $1b valuation long term.
But $20 is my swing trade target price right now.
All hurdles are cleared. They just have to execute now.
I honestly see them clawing their way back a $1b valuation long term.
But $20 is my swing trade target price right now.
Posted on 2/27/24 at 9:44 pm to ATLsuTiger
I break even at $9-10. At $50M or so market cap, I’m still in the camp it goes to zero or a multi-bagger within the next 12-18mos.
Posted on 3/7/24 at 6:30 pm to LSUcam7
quote:
Q4 2023 Financial Highlights
Q4 Revenue was approximately $21.0 million.
Q4 Gross Margin was approximately 47.1%.
Q4 Net Loss was approximately $6.9 million, down 65% from $19.5 million year over year.
Q4 adjusted EBITDA loss was approximately $0.7 million, down 95% from $15.2 million year over year.
Fiscal Year 2023 Financial Highlights
FY 2023 Revenue was approximately $54.0 million.
FY 2023 Gross Margin was approximately 41.8%, up 810 basis points from 33.7% in 2022.
FY 2023 Net Loss was approximately $32.9 million, down 59% from $79.3 million in 2022.
FY 2023 adjusted EBITDA loss was approximately $16.3 million, down 76% from $68.3 million year over year.
Nice revenue ramp up following a disastrous year in 2022. Market cap now less than revenues.
I still don’t know what to make of that valuation. Market pricing as if it’s going BK?
Given the cash burn, I’d imagine OWLT is going to continue having to tap capital markets to stay afloat.
They’ve also been talking Europe for a while now. Hopefully some new distribution methods can quickly produce.
Posted on 8/12/24 at 4:38 pm to LSUcam7
https://investors.owletcare.com/news/news-details/2024/Owlet-Announces-Strong-Second-Quarter-2024-Results-Achieves-Record-Breaking-Amazon-Prime-Day/default.aspx
quote:
Owlet Announces Strong Second Quarter 2024 Results, Achieves Record-Breaking Amazon Prime Day
08/12/2024
LEHI, Utah--(BUSINESS WIRE)-- Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2024. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, August 12, 2024, at 4:30 p.m. ET.
Q2 2024 Financial Highlights:
Obtained CE Medical certification for UK and Europe, launching Dream Sock across major European markets.
Q2 Revenue was approximately $20.7 million, up approximately 58% year over year.
Q2 Gross Margin was approximately 50%, up approximately 1,000 basis points year over year.
Q2 Net Loss was approximately ($1.1) million, improving approximately 85% compared to Net Loss of approximately ($8.5) million year over year.
Q2 adjusted EBITDA was approximately $0.1 million compared to adjusted EBITDA loss of ($4.3) million in the same prior year period.
Posted on 8/12/24 at 4:53 pm to ATLsuTiger
Awesome margins and seems like a true inflection point.
Guiding for full year revenue around $75M. The market cap is ~$45M.
Guiding for full year revenue around $75M. The market cap is ~$45M.
Posted on 8/12/24 at 5:05 pm to LSUcam7
They will be doing $200m+ in revenue by 2027. No brainer buy and hold for the next several years.
Posted on 8/12/24 at 5:11 pm to ATLsuTiger
Agreed. I was very skeptical that they’d make it through the last year or so.
But they’ve been running the ship extremely lean and it probably taught Workman quite a bit that he’ll be able to carry forward.
But they’ve been running the ship extremely lean and it probably taught Workman quite a bit that he’ll be able to carry forward.
Posted on 8/12/24 at 5:54 pm to ATLsuTiger
Nvm. Found it.
I continue to forget about the dilutive effects of the warrants / preferred stock. I’m no CFA, but trying my best to use this investment to learn more about valuing a company.
Looking at price x float just doesn’t give an accurate picture of the market cap considering Kurt’s reference to the convertible preferred stock & warrants.
I continue to forget about the dilutive effects of the warrants / preferred stock. I’m no CFA, but trying my best to use this investment to learn more about valuing a company.
Looking at price x float just doesn’t give an accurate picture of the market cap considering Kurt’s reference to the convertible preferred stock & warrants.
This post was edited on 8/12/24 at 6:04 pm
Posted on 8/12/24 at 6:27 pm to LSUcam7
quote:
Owlet, Inc. (NYSE: OWLT) has recently engaged in private placements involving convertible preferred stock and warrants, structured as follows:
1. **Series A Convertible Preferred Stock**:
- **Conversion**: Holders can convert each share into approximately 145.77 shares of common stock.
- **Warrants**: Accompanying the Series A preferred stock, warrants were issued that allow the purchase of common stock at an exercise price of $4.66 per share. These warrants are exercisable until February 2028.
- **Redemption**: The Series A shares can be redeemed at $1,000 per share, plus any unpaid dividends, under certain conditions, or they can be converted to common stock at a specified rate.
2. **Series B Convertible Preferred Stock**:
- **Conversion**: Each share is convertible into about 129.66 shares of common stock.
- **Warrants**: The Series B preferred stock also comes with warrants allowing holders to purchase additional shares of common stock. The exercise price for these warrants is $7.71 per share, and they are exercisable until March 2029.
- **Redemption and Voting Rights**: The Series B shares also include provisions for redemption and voting, similar to those of the Series A stock, but with different conversion rates and seniority conditions.
Per ChatGPT
These offerings were really attractive to the holders. Lots of equity option built in.
Posted on 8/12/24 at 6:29 pm to LSUcam7
Always best to factor in total dilutive share count. It’s close to 30m I believe.
But I still feel that a p/s of 3 is where fair valuation is for this company. Apply that to their worst case expected 2024 number of $71m, this should be trading at closer to $7 imo.
But I still feel that a p/s of 3 is where fair valuation is for this company. Apply that to their worst case expected 2024 number of $71m, this should be trading at closer to $7 imo.
Posted on 8/12/24 at 6:38 pm to ATLsuTiger
30M sounds right. I’ve done this exercise before and can’t find it.
I think valuation is still mostly related to the negative shareholder equity.
Either way solid margins and back to back bounces in revenue reaccelerating.
The Euro clearances are only going to help going forward. Opens the door to grow top line much faster.
ETA:
Series A (Feb ‘23) - 61.2M shares
- Warrants: “Each purchaser will also receive a warrant to purchase 180% of the number of shares of common stock into which their Series A preferred stock is convertible. The warrants will have a per share exercise price of $0.333 and will be exercisable by the holder at any time on or after the issuance date for a period of five years.”
OWLT IR
Series B (Feb ‘24) - 1.2M shares
- Each purchaser will also receive a warrant to purchase 150% of the number of shares of common stock into which their Series B preferred stock is convertible. The warrants will have a per share exercise price of $7.7125 and will be exercisable by the holder at any time on or after the issuance date for a period of five years.
OWLT IR
I’ve got to be reading this wrong. No way these offer an additional ~62M shares. Plus the warrant which could be another ~112M shares.
I think valuation is still mostly related to the negative shareholder equity.
Either way solid margins and back to back bounces in revenue reaccelerating.
The Euro clearances are only going to help going forward. Opens the door to grow top line much faster.
ETA:
Series A (Feb ‘23) - 61.2M shares
- Warrants: “Each purchaser will also receive a warrant to purchase 180% of the number of shares of common stock into which their Series A preferred stock is convertible. The warrants will have a per share exercise price of $0.333 and will be exercisable by the holder at any time on or after the issuance date for a period of five years.”
OWLT IR
Series B (Feb ‘24) - 1.2M shares
- Each purchaser will also receive a warrant to purchase 150% of the number of shares of common stock into which their Series B preferred stock is convertible. The warrants will have a per share exercise price of $7.7125 and will be exercisable by the holder at any time on or after the issuance date for a period of five years.
OWLT IR
I’ve got to be reading this wrong. No way these offer an additional ~62M shares. Plus the warrant which could be another ~112M shares.
This post was edited on 8/12/24 at 8:11 pm
Posted on 8/13/24 at 8:06 am to LSUcam7
Last time I spoke with IR about this, the fully diluted count was about 21m shares. This was in February.
Posted on 7/10/25 at 10:17 am to Choot em Tiger
Finally fairly valued once you account for the remaining warrant shares. I exited my swing position this week. Good luck to those still riding the wave!
Popular
Back to top

1





